文献速递神经肿瘤

转录组测序揭示硼中子俘获治疗抑制U87皮下肿瘤生长的分子机制

Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor.
PubMed 文献 · J Neurooncol · 2026-01-05

该研究利用U87胶质瘤细胞和小鼠皮下荷瘤模型,设对照组、单纯中子照射组、单纯BPA组及BPA联合中子照射组,通过转录组测序分析BNCT治疗后的基因表达谱与富集通路。结果显示BNCT显著抑制U87皮下肿瘤生长,富集于细胞周期与细胞死亡通路,筛选出与胶质瘤预后相关的FANCI、UHRF1和BEX2基因。BNCT促进凋亡、抑制铁死亡,并通过死亡受体FAS和TNFRSF10B诱导外源性凋亡。

要点

  • BNCT显著抑制U87皮下肿瘤生长,富集于细胞周期和细胞死亡通路。
  • 筛选出与胶质瘤预后相关的细胞周期基因FANCI、UHRF1和BEX2。
  • BNCT通过死亡受体FAS和TNFRSF10B诱导外源性凋亡。

核心结论

  • BNCT诱导与预后基因FANCI、UHRF1和BEX2相关的细胞周期变化。
  • BNCT主要通过FAS和TNFRSF10B等死亡受体途径诱导外源性凋亡。
  • 该研究为BNCT临床治疗胶质瘤提供潜在治疗靶点和理论依据。

研究设计与样本

  • 研究采用人胶质瘤细胞系U87评估BNCT的细胞毒性。
  • U87荷瘤小鼠分为四组:对照组(未处理)、N20组(仅中子照射)、BPA组(仅500 mg/kg BPA)、500N20组(500 mg/kg BPA联合中子照射)。
  • 中子束来自福建医科大学附属协和医院妈祖分院。
  • 采用转录组测序分析BNCT治疗后的基因表达谱、功能富集通路和关键调控网络。

主要发现

  • 500N20组对U87皮下肿瘤具有明显抑制作用。
  • GO和KEGG功能富集分析显示BNCT治疗后肿瘤显著富集于细胞周期和细胞死亡通路。
  • 筛选出三个与胶质瘤预后相关的细胞周期相关基因:FANCI、UHRF1和BEX2。
  • BNCT促进凋亡、抑制铁死亡,并诱导由死亡受体FAS和TNFRSF10B介导的外源性凋亡。

临床怎么用

  • 为BNCT临床治疗胶质瘤提供潜在疗效靶点FANCI、UHRF1和BEX2。
  • 提示BNCT抗胶质瘤作用与死亡受体FAS和TNFRSF10B介导的外源性凋亡相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BNCT is known as the “fifth therapy” after surgery, traditional radiotherapy, anti-cancer drugs and immunotherapy. It has prominent clinical advantages for brain tumors. PURPOSE: The aim of this study is to reveal the underlying mechanism of BNCT in the treatment of glioblastoma through transcriptome analysis, and to provide new theoretical basis and potential therapeutic targets for its clinical application. METHODS: The neutron beam was derived from Mazu Branch of the Union Hospital Affiliated to Fujian Medical University. Human glioma cell lines U87 was used to evaluate the cytotoxicity of BNCT. U87 tumor-bearing mice were divided into four groups: Control (untreated); N20 (neutron irradiation only); BPA (500 mg/kg BPA only); and 500N20 (500 mg/kg BPA plus neutron irradiation). Transcriptome sequencing was used to analyze gene expression profiles, functional enrichment pathways and key regulatory networks after BNCT treatment. RESULTS: 500N20 has obvious inhibitory effect on U87 subcutaneous tumor. GO and KEGG functional enrichment analysis showed that tumors after BNCT were significantly enriched in cell cycle and cell death pathways. Three cell cycle-related genes FANCI, UHRF1 and BEX2 related to the prognosis of glioma were screened out. In addition, BNCT promotes apoptosis, inhibits ferroptosis, and induces exogenous apoptosis induced by the death receptors FAS and TNFRSF10B. CONCLUSION: BNCT induced cell cycle changes associated with prognostic genes FANCI, UHRF1 and BEX2. BNCT induces extrinsic apoptosis mainly through the pathway of death receptors such as FAS and TNFRSF10B. This study provides potential therapeutic targets and theoretical basis for BNCT clinical treatment of glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Huang H, Gao F, Quan R, et al. Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor. J Neurooncol. 2026. PMID: 41491047. doi:10.1007/s11060-025-05360-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。